Who owns the AMPOLGEN PHARMACEUTICALS trademark?

The AMPOLGEN PHARMACEUTICALS trademark is owned by Ampolgen Pharmaceuticals, LLC.

What is the serial number for AMPOLGEN PHARMACEUTICALS?

The USPTO serial number for AMPOLGEN PHARMACEUTICALS is 78388886.

What is the registration number for AMPOLGEN PHARMACEUTICALS?

AMPOLGEN PHARMACEUTICALS is registered under USPTO registration number 3142996.

AMP

USPTO Trademark Record

REGISTERED

AMPOLGEN PHARMACEUTICALS

Q: What class is the AMPOLGEN PHARMACEUTICALS trademark registered in?

The AMPOLGEN PHARMACEUTICALS trademark is registered in Class 035 (Advertising, business management & retail services), Class 042 (Scientific, technology & SaaS services).

SN 78388886·Reg 3142996·Filed Mar 23, 2004

Owner Ampolgen Pharmaceuticals, LLC

Advertising; business management, organization and administration; office functions.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

AMPOLGEN PHARMACEUTICALS (Serial No. 78388886), Registration No. 3142996, is a registered US trademark filed on Mar 23, 2004 by Ampolgen Pharmaceuticals, LLC. This trademark covers Class 035 (Advertising, business management & retail services), Class 042 (Scientific, technology & SaaS services).

Section 8/9 declaration window: September 12, 2036

Mark Intelligence

AMPOLGEN PHARMACEUTICALS (Reg. #3142996) is a registered US trademark that has been protecting its owner, Ampolgen Pharmaceuticals, LLC, since 2004. The mark covers Class 035 (Advertising, business management & retail services) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Advertising; business management, organization and administration; office functions.; Scientific and technological servi.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 23, 2004

SERIAL

78388886

REG#

3142996

REGISTERED

Sep 12, 2006

Owner

Applicant

Ampolgen Pharmaceuticals, LLC

Entity

Corporation

State

Address

9432 Old Katy Road, Suite 200, Houston, TX, 77055

Country

Attorney

Law firm

Ampolgen Pharmaceuticals, LLC

Docket

85556-537654

Address

9432 Old Katy Road, Suite 200, Houston, TX 77055, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateMar 23, 2004

Serial Number78388886

Registration No.3142996

Registration DateSep 12, 2006

Status DateJan 10, 2026

Published for OppositionAug 30, 2005

Next RenewalSeptember 12, 2036

Mark TypeStandard characters

Attorney Docket85556-537654

Status DescriptionLive and registered, renewed

Filing Signals

FILED

2004

YEARS AGO

22y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 035Advertising, business management & retail services

US codes: 100, 101, 102

First use anywhere: Oct 21, 2005

First use in commerce: Oct 21, 2005

Advertising; business management, organization and administration; office functions.

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Oct 21, 2005

First use in commerce: Oct 21, 2005

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

37 events

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Jan 10, 2026

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Jan 10, 2026

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

Jan 10, 2026

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Jan 10, 2026

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

TEAS SECTION 8 & 9 RECEIVED

Sep 29, 2025

TEAS SECTION 8 & 9 RECEIVED

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Sep 12, 2025

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Nov 12, 2016

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Nov 12, 2016

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Nov 12, 2016

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Nov 12, 2016

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

TEAS SECTION 8 & 9 RECEIVED

Aug 30, 2016

TEAS SECTION 8 & 9 RECEIVED

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Sep 12, 2015

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Sep 24, 2012

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (6-YR) ACCEPTED

Sep 24, 2012

REGISTERED - SEC. 8 (6-YR) ACCEPTED

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Sep 24, 2012

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

TEAS SECTION 8 RECEIVED

Sep 12, 2012

TEAS SECTION 8 RECEIVED

REGISTERED-PRINCIPAL REGISTER

Sep 12, 2006

REGISTERED-PRINCIPAL REGISTER

LAW OFFICE REGISTRATION REVIEW COMPLETED

Jul 31, 2006

LAW OFFICE REGISTRATION REVIEW COMPLETED

ASSIGNED TO LIE

Jul 07, 2006

ASSIGNED TO LIE

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jun 26, 2006

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

STATEMENT OF USE PROCESSING COMPLETE

May 26, 2006

STATEMENT OF USE PROCESSING COMPLETE

TEAS CHANGE OF CORRESPONDENCE RECEIVED

May 16, 2006

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS STATEMENT OF USE RECEIVED

May 16, 2006

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

May 16, 2006

USE AMENDMENT FILED

NOA MAILED - SOU REQUIRED FROM APPLICANT

Nov 22, 2005

NOA MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Aug 30, 2005

PUBLISHED FOR OPPOSITION

NOTICE OF PUBLICATION

Aug 10, 2005

NOTICE OF PUBLICATION

LAW OFFICE PUBLICATION REVIEW COMPLETED

Apr 27, 2005

LAW OFFICE PUBLICATION REVIEW COMPLETED

ASSIGNED TO LIE

Apr 22, 2005

ASSIGNED TO LIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 19, 2005

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 15, 2005

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 04, 2005

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 04, 2005

CORRESPONDENCE RECEIVED IN LAW OFFICE

ASSIGNED TO EXAMINER

Oct 04, 2004

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Oct 04, 2004

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Oct 04, 2004

NON-FINAL ACTION E-MAILED

NEW APPLICATION ENTERED

Apr 01, 2004

NEW APPLICATION ENTERED

AMPOLGEN PHARMACEUTICALS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks in Class 035 — Advertising, business management & retail services

Resources

Company